News about "Gaurav Mehta, CEO of Alveolus Bio"

Shilpa Medicare Backs Alveolus Bio with Strategic Funding, Becomes Global Manufacturing Partner for Inhaled Respiratory Therapies

Shilpa Medicare Backs Alveolus Bio with Strategic Funding, Becomes Global Manufacturing Partner for Inhaled Respiratory Therapies

Known for its strong capabilities in biotechnology and respiratory therapeutics manufacturing, Shilpa Medicare—through its biologics arm, Shilpa Biologics—will serve as Alveolus Bio’s exclusive global development and manufacturing partner.

Gaurav Mehta, CEO Of Alveolus Bio | 07/08/2025 | By Darshana


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members